Mastering increasing complexity in developing innovative therapies
Program of the conference
The conference will delve into the evolving landscape of early-phase clinical trials, featuring discussions on the role of genetic medicines, challenges in innovative therapy development, and the integration of artificial intelligence in clinical research. Attendees can anticipate engaging keynote presentations, panel discussions, and breakout sessions led by experts from academia, industry, and regulatory bodies. We also offer valuable networking opportunities, including a social event on May 22.
Download the full program here or have a look at the schedule online.
